Mach F - Search Results

1

[PCSK9 inhibitors: emerging treatment to lower cholesterol?].

Gencer B, Rodondi N, Mach F. Gencer B, et al. Among authors: mach f. Rev Med Suisse. 2014 Mar 5;10(420):539-42, 544. Rev Med Suisse. 2014. PMID: 24701672 French.

2

[A Swiss multicentric project to improve the prevention of cardiovascular event recurrence after acute coronary syndromes].

Carballo D, Auer R, Carballo S, Windecker S, Matter C, Luscher T, Vogt P, Perneger T, Mach F, Rodondi N, Keller PF; SPUM-ACS. Carballo D, et al. Among authors: mach f. Rev Med Suisse. 2010 Mar 10;6(239):518, 520-2, 524. Rev Med Suisse. 2010. PMID: 20373699 Clinical Trial. French.

3

[Role of percutaneous coronary intervention in diabetic patients].

Gencer B, Noble S, Bonvini RF, Mach F, Roffi M. Gencer B, et al. Among authors: mach f. Rev Med Suisse. 2013 May 29;9(388):1137-8, 1140-1. Rev Med Suisse. 2013. PMID: 23789182 Review. French.

4

Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications.

Auer R, Gencer B, Räber L, Klingenberg R, Carballo S, Carballo D, Nanchen D, Cornuz J, Vader JP, Vogt P, Jüni P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N. Auer R, et al. Among authors: mach f. PLoS One. 2014 Mar 27;9(3):e93147. doi: 10.1371/journal.pone.0093147. eCollection 2014. PLoS One. 2014. PMID: 24676282 Free PMC article.

5

[Testosterone: a treatment for the prevention of cardiovascular disease].

Gencer B, Köhler Ballan B, Philippe J, Mach F. Gencer B, et al. Among authors: mach f. Rev Med Suisse. 2014 May 28;10(432):1173-8. Rev Med Suisse. 2014. PMID: 24964524 Review. French.

6

Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes.

Gencer B, Rodondi N, Auer R, Räber L, Klingenberg R, Nanchen D, Carballo D, Vogt P, Carballo S, Meyer P, Matter CM, Windecker S, Lüscher TF, Mach F. Gencer B, et al. Among authors: mach f. Eur J Intern Med. 2015 Jan;26(1):56-62. doi: 10.1016/j.ejim.2014.12.014. Epub 2015 Jan 10. Eur J Intern Med. 2015. PMID: 25582072

7

Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes.

Gencer B, Auer R, Nanchen D, Räber L, Klingenberg R, Carballo D, Blum M, Vogt P, Carballo S, Meyer P, Matter CM, Windecker S, Lüscher TF, Mach F, Rodondi N. Gencer B, et al. Among authors: mach f. Atherosclerosis. 2015 Mar;239(1):118-24. doi: 10.1016/j.atherosclerosis.2014.12.049. Epub 2015 Jan 6. Atherosclerosis. 2015. PMID: 25585031

8

[Statin treatment in primary and secondary prevention--a statement].

Mach F, Riesen WF, Rodondi N, Von Eckardstein A. Mach F, et al. Rev Med Suisse. 2014 Dec 17;10(455):2430-3. Rev Med Suisse. 2014. PMID: 25752015 French.

9

Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland.

Klingenberg R, Heg D, Räber L, Carballo D, Nanchen D, Gencer B, Auer R, Jaguszewski M, Stähli BE, Jakob P, Templin C, Stefanini GG, Meier B, Vogt P, Roffi M, Maier W, Landmesser U, Rodondi N, Mach F, Windecker S, Jüni P, Lüscher TF, Matter CM. Klingenberg R, et al. Among authors: mach f. Heart. 2015 Jun;101(11):854-63. doi: 10.1136/heartjnl-2014-306925. Epub 2015 Mar 20. Heart. 2015. PMID: 25794517 Clinical Trial.

10

Sweetless'n low LDL-C targets for PCSK9 treatment.

Gencer B, Mach F. Gencer B, et al. Among authors: mach f. Eur Heart J. 2015 May 14;36(19):1146-8. doi: 10.1093/eurheartj/ehv056. Epub 2015 Mar 31. Eur Heart J. 2015. PMID: 25827601 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters